The "Jext Pen" from the pharmaceutical company ALK Abelló can save the lives of allergy sufferers in the event of a severe reaction. In order to make the handling easier to understand, the B2IMPACT a brochure.
In the case of a strong allergic reaction, quick action is required. For example, if you are allergic to bees or similar insects and you are stung, then in the worst case a so-called anaphylactic shock can occur. This can be accompanied by shortness of breath, sweating, dizziness, nausea, a drop in blood pressure and unconsciousness. The pharmaceutical company ALK Abelló offers the "Jext Pen" for allergy sufferers and emergency responders.
The Jext Pen is applied intramuscularly to the outer thigh and can be used through clothing or directly on the skin. In short, the Jext Pen is designed to save lives. However, the product can only do this if it is handled correctly.
Struggle for more attention
To make their Jext Pen product brochure easy to understand for young people and adults, ALK Abelló turned to the creative minds of the B2IMPACT agency. The task: to raise awareness among younger patients and to provide good support for the educational work of anaphylaxis.
Thanks to numerous clients from the pharmaceutical industry, we can draw on sound expertise in this field. The concept was therefore quickly clear to us: after reviewing old marketing materials, we decided on a redesign with fewer but clearer pages plus an emergency passport and a gimmick in the form of an emergency pouch for the Jext pen.
Pharmaceutical company with history
ALK Abelló is a more research-oriented global pharmaceutical company specialising in the prevention, diagnosis and treatment of allergies. ALK Abelló is one of the key pioneers of specific immunotherapy - a unique treatment that not only relieves allergy symptoms but also addresses the cause of allergy. The company employs approximately 2,000 people worldwide and has offices, manufacturing facilities and distributors around the globe. ALK Abelló products are currently used by around 1.5 million people worldwide.
For almost a century, ALK Abelló has been a pioneer in the causal treatment of allergies. The company's history can be traced back to 1923 to a small laboratory in Copenhagen, Denmark.